+++Taylor & Francis 7 шт Спасибо FIN1!!

[гаер*]

Дорогие коллеги, поделитесь, пожалуйста, статьями:

1
Goldenberg & Sharkey, Sacituzumab govitecan, a novel, third-generation, antibody-drug conjugate (ADC) for cancer therapy
Expert Opin. Biol. Ther. 2020, 20(8), 871-885

DOI:

http://dx.doi.org/10.1080/14712598.2020.1757067

2
Fujii & Matsuda, Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry
Expert Opin. Biol. Ther. 2023, 23(11), 1053-1065

DOI:

http://dx.doi.org/10.1080/14712598.2023.2276873

3
Leyton, The endosomal-lysosomal system in ADC design and cancer therapy
Expert Opin. Biol. Ther. 2023, 23(11), 1067-1076

DOI:

http://dx.doi.org/10.1080/14712598.2023.2285996

4
Gan et al., Antibody drug conjugates for glioblastoma: current progress towards clinical use
Expert Opin. Biol. Ther. 2023, 23(11), 1089-1102

DOI:

http://dx.doi.org/10.1080/14712598.2023.2282729

5
Hartley, Antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) dimers for cancer therapy
Expert Opin. Biol. Ther. 2021, 21(7), 931-943

DOI:

http://dx.doi.org/10.1080/14712598.2020.1776255

6
Matsuda & Mendelsohn, An overview of process development for antibody-drug conjugates produced by chemical conjugation technology
Expert Opin. Biol. Ther. 2021, 21(7), 963-975

DOI:

http://dx.doi.org/10.1080/14712598.2021.1846714

7
Silic-Benussi et al., Near infrared photoimmunotherapy targeting the cutaneous lymphocyte antigen for mycosis fungoides
Expert Opin. Biol. Ther. 2021, 21(7), 977-981

DOI:

http://dx.doi.org/10.1080/14712598.2021.1858791

Заранее благодарен!

[FIN1]

1

[FIN1]

2

[FIN1]

3

[FIN1]

5

[FIN1]

4

[FIN1]

7

[FIN1]

6